Eli Lilly’s combination antibody therapy for COVID-19 cuts risk of hospitalization and death by 87%

The closest thing to a COVID ‘cure’? Eli Lilly’s combination antibody drug cuts the risk of COVID-19 hospitalization and death by 87%, study finds The combination treatment, a mixture of two drugs, recognizes the coronavirus and attaches to it, preventing it from spreading throughout the body   Half a group of 769 mild-to-moderate COVID-19 patients at … Read more

US FDA grants emergency approval for Eli Lilly’s coronavirus antibody drug

The U.S. Food and Drug Administration on Monday (FDA) authorized emergency use of Eli Lilly and Co’s experimental COVID-19 antibody treatment, which President Donald Trump has praised and vowed to make available free of cost for all Americans. The FDA said its emergency use authorization was based on clinical trials showing that the treatment, bamlanivimab, … Read more

US FDA grants emergency approval for Eli Lilly’s coronavirus antibody drug

The U.S. Food and Drug Administration on Monday (FDA) authorized emergency use of Eli Lilly and Co’s experimental COVID-19 antibody treatment, which President Donald Trump has praised and vowed to make available free of cost for all Americans. The FDA said its emergency use authorization was based on clinical trials showing that the treatment, bamlanivimab, … Read more

Eli Lilly’s antibody drug lowers viral loads and improves symptoms in mildly ill COVID-19 patients

Eli Lilly & Co’s coronavirus antibody treatment can almost completely reduce viral loads in COVID-19 patients to zero and lowers the risk of hospitalization. Researchers found that mildly and moderately ill patients given a high dose of the antibody, LY-CoV555 (also known as bamlanivimab), had viral loads that were 3.4 times lower than those who … Read more

Trials for EIi Lilly’s coronavirus antibody treatment paused

President Trump has been given at least three potent drugs since announcing he tested positive for COVID-19 on Thursday night: Regeneron’s cocktail of lab-made antibodies, the antiviral remdesivir, and the steroid dexamethasone.  Two of those medications are still experimental for treating COVID-19, and have given emergency use authorization by the Food and Drug Administration (FDA).  … Read more